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A B S T R A C T
The aims were to determine the benefit of bilateral cochlear implantation in a 20 years old patient implanted in
Croatia on hearing and speech development. The male patient, after 10 years of deafness, got cochlear implants Med-EL
Combi 40+ on both sides in one-stage surgery. The etiology of his deafness was posttraumatic meningitis. Auditory ca-
pacity and speech recognition tests were performed for both ears separately and together. Average hearing level on the
right ear with right cochlear implant switched on started at 62 dB 1 month after the cochlear implantation and was on
55 dB after 10 years. Average hearing level on the left ear with left cochlear implant switched on started at 55 dB 1 month
after the cochlear implantation and was on 32 dB after 10 years. Average hearing level on the both ears with 2 cochlear
implants switched on started at 35 dB 1 month after the cochlear implantation and was on 27 dB after 10 years. Long-
-term functional outcomes with bilateral cochlear implantation provides advantages over unilateral implantation in-
cluding improved hearing level, speech perception in noise and improved sound localization.
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Introduction
Cochlear implantation started in Croatia in 1996.
First cochlear implant was MED-EL Combi 40, implan-
ted in the Department of Otorhinolaryngology & Head
and Neck Surgery, »Sestre milosrdnice« University Hos-
pital Center in Zagreb. Since than, cochlear implantation
started also in Salata ENT department, and in ENT de-
partments in Rijeka and Split. Several cochlear implants
are commercially available in Croatia: the Nucleus®
family of devices, manufactured by Cochlear™ Corpora-
tion, the Clarion® family of devices, manufactured by
Advanced Bionics®; and the Med El Combi 40+ and So-
nata device, manufactured by Med El Corporation. While
cochlear implants have typically been used mono later-
ally, in recent years, interest in bilateral cochlear implan-
tation has arisen2–4. The proposed benefits of bilateral co-
chlear implants are to improve understanding of speech
in noise and localization of sounds1. Improvements in
speech intelligibility may occur with bilateral cochlear
implants through binaural summation; i.e., signal pro-
cessing of sound input from two sides may provide a
better representation of sound and allow one to separate
out noise from speech7,9. Speech intelligibility and local-
ization of sound or spatial hearing may also be improved
with head shadow and squelch effects, i.e., the ear that is
closest to the noise will be received at a different fre-
quency and with different intensity, allowing one to sort
out noise and identify the direction of sound10,11. Bilat-
eral cochlear implantation may be performed independ-
ently with separate implants and speech processors in
each ear or with a single processor19,20,22. Unilateral or bi-
lateral implants with FDA-approved cochlear implant(s)
and associated aural rehabilitation may be considered
medically necessary when all of the following criteria are
met: age one year or older, severe to profound pre-or
postlingual hearing loss, defined as a hearing threshold
of 70 decibels (dB) or above and limited benefit from
hearing aids unless hearing aids are unreasonable5,6,15.
Contraindications for cochlear implantation include: deaf-
ness due to lesions of the acoustic nerve or central audi-
tory pathways, otitis media or other active, unresolved
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ear problems, radiographic evidence of absent cochlear
development and inability or lack of willingness to par-
ticipate in post-implantation aural rehabilitation8,16,18.
Cochlear Implant Device
A cochlear implant provides direct electrical stimula-
tion to the auditory nerve, bypassing the usual trans-
ducer cells that are absent or non-functional in deaf co-
chlea. The basic components of a cochlear implant in-
clude both external and internal components. The exter-
nal components include a microphone, an external sound
processor, and an external transmitter. The internal com-
ponents are implanted surgically and include an internal
receiver implanted within the temporal bone, and an
electrode array that extends from the receiver into the
cochlea through a surgically created opening in the round
window of the middle ear. Sounds that are picked up by
the microphone are carried to the external signal proces-
sor, which transforms sound into coded signals that are
then transmitted transcutaneously to the implanted in-
ternal receiver. The receiver converts the incoming sig-
nals to electrical impulses that are then conveyed to the
electrode array, ultimately resulting in stimulation of the
auditory nerve29,30,33.
Cochlear Implant Surgery
Cochlear implant surgery lasts about two to three
hours and is performed while the patient is under gen-
eral anesthesia. After mastoidectomy, posterior tympa-
notomy and cochleostomy, the electrode array is inserted
into the cochlea. The receiver/stimulator is secured to
the skull on the temporal bone. At the end of the opera-
tion the implant is tested by attaching it to the processor
and making sure that it is functioning well12,13,15,34.
Rehabilitation
A post-cochlear implant rehabilitation program is ne-
cessary to achieve benefit from the cochlear implant. The
rehabilitation program start one month after surgery
and includes development of skills in understanding run-
ning speech, recognition of consonants and vowels, and
tests of speech perception ability by the use of SUVAG,s
verbo-tonal method of rehabilitation21,23,24,26,28.
Results
20 years old male patient underwent two simulta-
neously – implanted bilateral cochlear implant surgery.
Figure 1 shows preoperative pure tone audiometry (PTA)
in 20 years old male patient. Hearing level (HL) on the
left ear was between 85 dB on 125 Hz and 120 dB on 1000
Hz. On the right ear HL was between 80 dB on 125 Hz
and 120 dB on 2000.
Figure 2 shows PTA 6 months postoperativelly with
separate bilateral CI swithed on. When left CI was swit-
ched on and right CI switched off HL on the left ear was
between 20 dB and 50 dB. The mean PTA on 4 frequen-
cies (500, 1000, 2000 and 4000 Hz) was 30 dB HL
(SD=20). When right CI was switched on and left CI
switched off HL on the right ear was between 25 dB and
90 dB. The mean PTA was 56 dB HL (SD=34).
Figure 3 shows PTA 6 months postoperativelly with
both CI swithed on. HL on the left ear was between 20 dB
and 70 dB. The mean PTA was 28 dB HL (SD=42). HL
on the right ear was between 20 dB and 70 dB. The mean
PTA was 30 dB HL (SD=40).
Figure 4 shows speech audiogram 6 months post-
operativelly with both CI swithed on. HL was on 25 dB,
and 70% recognition was on 45 dB.
As the result of the speech recognition in the presence
of noise, we found in this simultaneously – implanted bi-
lateral cochlear implant user, that he was able to sustain
a 50% correct score on the BKB-SIN test at a lower sig-
nal-to-noise (SNR) ratio using his bilateral implants than
when using only one of his implants. When only one im-
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Fig. 1. Preoperative PTA.
Fig. 2. PTA 6 months postoperativelly with separate bilateral CI
swithed on.
Fig. 3. PTA 6 months postoperativelly with both CI switched on.
plant was used, the SNR had to be increased to more fa-
vourable levels in order for the subjects to sustain that
same performance level. In each of the three test condi-
tions (noise from the left, noise from in front, noise from
the right), these results were statistically significant af-
ter 3-months of bilateral implant use, with scores in-
creasing further at the 6 month test. The bilateral fitting
condition was superior regardless of the location of the
noise. This confirms the superiority of bilateral cochlear
implant use in recognizing speech in the presence of
noise.
Discussion
While use of a monolateral cochlear implant in pa-
tients with severe to profound hearing loss has become
standard clinical practice, bilateral cochlear implants has
been less common. A literature review through Decem-
ber 18, 2007 identified a number of studies that are rele-
vant to the use of bilateral cochlear implants. Sharma
and colleagues report that central auditory pathways are
maximally plastic for a period of about 3.5 years8,9,37.
Stimulation delivered within this period results in audi-
tory evoked potentials that reach normal values in three
to six months. However, when stimulation occurs after
seven years, changes occur within one month, but then
have little to no subsequent change. Sharma and Dor-
man also reported on auditory development in 23 chil-
dren with unilateral or bilateral implants.8 In one child
who received a bilateral device with later (after age
seven) implantation of the second ear the auditory re-
sponses in the second device were similar to that seen in
»late-implanted« children. A review of the peer-reviewed
literature on MEDLINE from the period of 1995 through
April 2006 identified 13 case reports on patients with bi-
lateral cochlear implants14,35. The case reports identified
range in size from 1 to 10 patients and most, but not all,
patients reported slight to modest improvements in sound
localization and speech intelligibility with bilateral co-
chlear implants especially with noisy backgrounds but
not necessarily in quiet environments. When reported,
the combined use of binaural stimulation improved hear-
ing in the range of 1–4 decibels or 1–2%. While this im-
provement seems slight, any improvement in hearing
can be considered beneficial in the deaf25,27,32. However,
this improvement appears marginal at best, and may not
outweigh the significant risks of a second implantation.
In addition, similar binaural results can be achieved with
a contralateral hearing aid, assuming the contralateral
ear has speech recognition ability16. A number of studies
have also reported results with bilateral cochlear im-
plants. Litovsky reported that nine of 13 (70%) children
with bilateral cochlear implants discriminated source
separations of equal to or less than 20 degrees and seven
out of nine performed better when using bilateral (versus
unilateral) devices4,10. Schoen and colleagues reported
that bilateral cochlear implants were able to restore spa-
tial hearing in eleven cochlear implant patients14. Litov-
sky and colleagues reported on a multi-center prospec-
tive study of 37 adults with post-lingual bilateral hearing
loss12. Bilateral benefit (speech understanding in quiet
and noise) was seen in 32/34 subjects. Questionnaire
data (subjects used only the best unilateral device for
three weeks) also indicated that bilateral users perceived
their performance to be better than when using a single
device. Ricketts and colleagues reported on 16 similar
adults with post-lingual bilateral hearing loss6. They
found a small but significant advantage for bilateral im-
plants for speech recognition in noise. While a training
effect was noted over time for a subset of patients fol-
lowed up to 17 months, a consistent bilateral advantage
was noted. Ramenden and colleagues reported on 30
adults in England who had bilateral cochlear implants
and received their second implant a mean of three years
after the first. At nine months a significant (12.6%,
p=less than 0.001) binaural advantage was seen for
speech and noise from the front. They were not able to
predict when the second ear would be the better per-
former. Sequential implantation with long delays be-
tween ears resulted in poor second ear performance for
some of their subjects. Kuhn-Uinacker reported on a
group of 39 European children who had bilateral co-
chlear implants13. From qualitative and quantitative da-
ta, they concluded that bilateral implants improve the
children’s communicative behavior, especially in complex
listening situations. Numerous positive benefits of bilat-
eral cochlear implantation have been confirmed38–40. Pa-
tients receive significant head shadow benefit from bilat-
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Fig. 4. Speech audiogram 6 months postoperativelly with both CI
switched on.
Fig. 5. Average hearing level 1–120 months after bilateral
cochlear implantation.
eral implantation, and obtain nominal benefits from
summation and squelch effects. Sound localization bene-
fits have been confirmed. Speech perception in noise
with bilateral implantation is significantly better than
unilateral implantation and continues to improve 24
months after implantation. Areas for further improve-
ment have also been identified. Despite technological im-
provements in speech processing strategies, measured
intraaural time differences in bilateral cochlear implant
recipients remain considerably greater than those with
normal hearing. Programming challenges persist to opti-
mize sound processing with bilateral implants31,35,36. Ves-
tibular effects of bilateral cochlear implantation appear
safe but need further study. Important considerations in-
cluding the duration of implant function, long-term com-
plication rate, and improvements in implant technology
will continue to strongly influence the role of bilateral co-
chlear implantation. There has been also some arguments
against simultaneous bilateral cochlear implantation: op-
erative time/risk of anaesthesia, increased surgical risk,
damage to residual hearing, financial expense, ability to
utilize future technological advancements and ability to
utilize future medical treatments-hair cell regeneration/
stem cell treatments. But, now we doing bilateral simul-
taneous bilateral cochlear implantation in 2½ to 2¾
hours, so operative time is not an issue. The risks are
minimal with cochlear implantation and the most com-
mon side effect we see is dizziness. Patients who get bi-
lateral simultaneous implants do not have any more
problems with their balance than unilateral implant pa-
tients. The concern about destroying residual hearing is
out of question, because recent studies showed residual
hearing after the cochlear implantation too. And about
costs-getting a bilateral simultaneous implantation saves
you the cost of two hospital stays, two recovery times,
and twice the anaesthesia. Because of that, many Insti-
tutes for Health Insurance in european countries ap-
prove two implants for deaf people. And, we can say that
cochlear implant technology has improved tremendou-
sly over the years. And there is no fear about utilizing fu-
ture technological advancements and future medical
treatments-hair cell regeneration/stem cell treatments17,35.
Conclusion
Bilateral cochlear implantation provides advantages
over unilateral implantation including improved speech
perception in noise and improved sound localization.
Further research is needed to define the optimal indi-
cations and to maximize the benefit of bilateral im-
plantation.
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DUGORO^NI FUNKCIONALNI DESETOGODI[NJI REZULTATI OBOSTRANE UGRADNJE
UMJETNIH PU@NICA
S A @ E T A K
Ciljevi su bili odrediti prednosti razvoja slu{anja i govora nakon obostrane ugradnje umjetnih pu`nica kod 20-godi-
{njeg pacijenta u Hrvatskoj. Mu{ki pacijent je dobio umjetne pu`nice na oba uha, tipa Med-El Combi 40+, nakon 10
godina gluho}e, u kirur{kom zahvatu obostrane ugradnje tijekom jednog kirur{kog zahvata. Uzrok njegove gluho}e bio
je posttraumatski meningitis. Audiolo{ki i govorni testovi napravljeni su posebno za svako uho, kao i za oba uha. Pro-
sje~ni prag sluha na desnom uhu, s uklju~enom desnom umjetnom pu`nicom, bio je 62 dB mjesec dana nakon ugradnje
umjetnih pu`nica te 55 dB 10 godina nakon ugradnje umjetnih pu`nica. Prosje~ni prag sluha na lijevom uhu, s uklju-
~enom lijevom umjetnom pu`nicom, bio je 55 dB mjesec dana nakon ugradnje umjetnih pu`nica, te 32 dB 10 godina
nakon ugradnje umjetnih pu`nica. Prosje~ni obostrani prag sluha, s uklju~ene dvije umjetne pu`nice, bio je 35 dB
mjesec dana nakon ugradnje umjetnih pu`nica te 27 dB 10 godina nakon ugradnje umjetnih pu`nica. Dugoro~ni funk-
cionalni rezultati 10 godina nakon ugradnje obostranih umjetnih pu`nica pokazuju da obostrana ugradnja umjetnih
pu`nica ima prednost pred jednostranom ugradnjom, uklju~iv{i bolji prosje~ni prag sluha, bolju razabirljivost u buci i
bolju lokalizaciju zvukova.
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